Clinical Trial

Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction

Name: Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction — clinical trial record (NCT05892042)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ACTonLVT

Recruiting

View on ClinicalTrials.gov →

Summary

Contemporary data are lacking regarding the management of left ventricular thrombus (LVT) developed after ST segment elevation myocardial infarction

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2023-05-28.

Trial Details

NCT Number	NCT05892042
Lead Sponsor	Jilin University
Conditions	ST-segment Elevation Myocardial Infarction (STEMI), Left Ventricular Thrombus
Enrollment	320 participants
Start Date	2023-05-01
Primary Completion	2026-09-01 (estimated)
Study Completion	2026-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-01